Fluorescence in situ hybridization, universally known as FISH, detects Down syndrome by lighting up chromosome 21 inside individual cells so that technicians can literally count the glowing signals. A normal cell produces two bright spots, one for each copy of chromosome 21. Three spots mean trisomy 21, the chromosomal basis of Down syndrome. What makes FISH valuable is speed: results can come back within 24 to 48 hours from an amniocentesis or chorionic villus sample, compared with the one to two weeks that traditional chromosome culturing requires. But the technique has both strengths and blind spots that matter for anyone trying to understand a prenatal or postnatal diagnosis.
How FISH Lights Up Chromosome 21
The basic idea is elegantly simple. Researchers build short stretches of DNA that are complementary to sequences found only on chromosome 21. These stretches, called probes, are tagged with a fluorescent dye. When the probes are applied to a sample of cells on a glass slide, they bind specifically to chromosome 21 and nowhere else. Under a fluorescence microscope, each copy of chromosome 21 glows as a discrete spot of color against the darker background of the rest of the genome.
The technique was first demonstrated for trisomy 21 in the late 1980s, when researchers showed that entire chromosome-specific DNA libraries could make a target chromosome at least 20 times brighter per unit length than other chromosomes, allowing trisomy 21 to be spotted in both dividing and non-dividing cells.1PubMed Central. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4 Around the same time, another group used plasmid clones containing DNA from band q22.3 of chromosome 21 and showed that a trisomic cell displays three discrete foci of hybridization, while a normal diploid cell shows two.2PubMed Central. Rapid detection of human chromosome 21 aberrations by in situ hybridization That core principle has not changed in the decades since, though the probes themselves have gotten more precise and commercially standardized.
Why Most Probes Target the 21q22 Region
Chromosome 21 is the smallest human autosome, but not every part of it matters equally for the features of Down syndrome. The probes used in clinical FISH testing tend to zero in on a region called 21q22, which sits on the long arm of the chromosome. This region contains what researchers have historically called the Down syndrome critical region, a stretch of DNA whose duplication alone is enough to produce many of the characteristic features of the condition.
A case report of a family carrying a 4.3 megabase duplication limited to bands q22.13 through q22.2 illustrates why this region is the diagnostic sweet spot. The duplication was first picked up by interphase FISH in a fetus with hydrops and was later confirmed in the mother and her eight-year-old daughter, both of whom carried the same partial duplication and showed features of Down syndrome.3PubMed Central. Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region Separately, a prenatal case of partial trisomy 21q22 caused by a cryptic paternal insertion into chromosome 4 was caught by overnight FISH on uncultured amniotic fluid cells. The baby was born at term with classical Down syndrome features.4PubMed. Down syndrome with pure partial trisomy 21q22 due to a paternal insertion (4;21) uncovered by uncultured amniotic fluid interphase FISH These examples show that FISH probes aimed at the critical region catch not just full trisomy but also partial duplications that produce the same clinical picture.
Interphase Versus Metaphase and Why It Matters
Cells go through phases. In metaphase, chromosomes line up neatly and are individually visible under a microscope, which is why traditional karyotyping requires cells to be cultured until enough of them are caught mid-division. FISH sidesteps this bottleneck by also working in interphase, the much longer resting phase when chromosomes are spread out inside the nucleus. You don’t need to grow cells for days if you can count fluorescent signals in interphase nuclei directly from the original sample.
This distinction carries real diagnostic weight. Composite probes for chromosomes 13, 18, and 21 can stain essentially the entire long arm of each target chromosome when applied to both interphase and metaphase amniocytes, making it possible to screen for the three most common autosomal trisomies in a single assay.5PubMed Central. Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes – Section: Abstract But interphase analysis occasionally reveals things that metaphase misses, and the reverse is also true. One instructive case involved a complex rearrangement of chromosome 21 in which FISH on 100 interphase nuclei showed three signals at the critical region, consistent with Down syndrome, yet standard G-banded karyotyping of metaphase cells from the same patient came back as a normal 46,XY karyotype.6Clinical Case Reports. Prenatal diagnosis of complex rearrangement of chromosome 21: The significance of interphase and metaphase fluorescence in situ hybridization and comparative genomic hybridization The discrepancy happened because the extra chromosome 21 material had been inserted into another chromosome in a way that looked normal on banding analysis. Without the interphase FISH result, the diagnosis would have been missed entirely.
Robertsonian Translocations and Other Structural Rearrangements
Not every case of Down syndrome involves a straightforward extra chromosome 21 floating free in the cell. In roughly 3 to 4 percent of cases, the extra chromosome 21 material is fused to another chromosome through what is called a Robertsonian translocation. The most common version involves chromosomes 14 and 21 stuck together, but fusions between 21 and chromosomes 13, 15, or 22 also occur. In rare cases, both copies of chromosome 21 fuse with each other.
FISH combined with conventional karyotyping plays a specific role here. A report from Mali described the first identification in that country of Down syndrome caused by a de novo Robertsonian translocation involving both copies of chromosome 21 fused together. Cytogenetic analysis combining karyotyping and FISH allowed accurate detection and characterization of the translocation.7Clinical Case Reports. Down Syndrome due to de Novo Robertsonian Translocation Rob(21;21) in Mali A study of five prenatal samples with Robertsonian translocations similarly used combined FISH and karyotype analysis to identify cases involving chromosomes 14, 15, 21, and 22 fused with chromosome 21, underscoring that FISH alone identifies the trisomy while karyotyping identifies which chromosomes are involved.8PubMed. Application of combined fluorescence in situ hybridization and karyotype analysis for the diagnosis of Robertsonian translocation type trisomy 21
This matters for genetic counseling. If a Robertsonian translocation is inherited from a parent, the recurrence risk in future pregnancies is significantly higher than for standard trisomy 21, which usually arises as a random event during egg or sperm formation. Identifying the translocation type determines the counseling conversation, and that identification requires both FISH and a full karyotype.
Detecting Mosaic Down Syndrome
Mosaicism means that some of a person’s cells carry trisomy 21 while others have the usual two copies. People with mosaic Down syndrome often have milder features, though the spectrum is wide. FISH is particularly useful for mosaicism because it lets technicians count signals in hundreds of individual interphase nuclei quickly, giving a cell-by-cell picture of how many trisomic versus normal cells are present in a sample.
A study of individuals with mosaic Down syndrome scored both lymphocytes from blood and buccal mucosa cells from cheek swabs using FISH. Buccal cells showed a significantly higher frequency of trisomy than lymphocytes from the same individuals. When patients were grouped by the number of Down syndrome traits they displayed, those with fewer traits had a lower percentage of trisomic cells, averaging about 37 percent trisomic lymphocytes, while those with more traits averaged around 54 percent trisomic lymphocytes.9PubMed Central. To investigate a potential “threshold” effect due to trisomic imbalance, lymphocyte and buccal mucosa nuclei were scored using FISH The finding that different tissues carry different proportions of trisomic cells has practical implications: a blood draw might underestimate the level of mosaicism compared with other tissue types. When mosaicism is suspected but blood results are ambiguous, testing a second tissue can be informative.
How Accurate Is FISH for Trisomy 21?
For straightforward trisomy 21, the accuracy is very high. A study of over 5,000 consecutive uncultured amniotic fluid samples detected all 70 cases of trisomy 21 by FISH, with every case confirmed by conventional karyotyping. There were no false positives and no false negatives, yielding 100 percent sensitivity and 100 percent specificity in that sample.10PubMed. Rapid prenatal diagnosis of trisomy 21 in 5049 consecutive uncultured amniotic fluid samples by fluorescence in situ hybridisation (FISH) A smaller study of 116 prenatal patients also reported no false-positive or false-negative results for autosomal aneuploidies and achieved a diagnostic detection rate of about 97.5 percent, with the shortfall accounted for by samples that failed to hybridize rather than by diagnostic errors.11PubMed Central. Rapid-prenatal diagnosis through fluorescence in situ hybridization for preventing aneuploidy related birth defects – Section: Results
These numbers are reassuring when the question is “does this fetus have trisomy 21, yes or no?” But they come with a caveat: FISH is designed to answer targeted questions about specific chromosomes. It does not survey the entire genome, so it cannot catch abnormalities on chromosomes it is not probing for.
What FISH Misses and Why Karyotyping Still Matters
The biggest limitation of FISH is its narrow focus. A standard prenatal FISH panel checks for trisomies 13, 18, and 21 plus the sex chromosomes. Everything else goes unexamined. A large retrospective analysis of over 9,000 samples found that FISH and karyotyping agreed on all 285 aneuploidy cases, but karyotyping also identified 68 structural chromosomal aberrations that FISH missed entirely. Of those, 28 were unbalanced rearrangements with potential clinical significance. In other words, about 0.3 percent of clinically significant findings would have been missed if FISH alone had been used.12Journal of Fetal Medicine. FISH is not Suitable as a Standalone Test for Detecting Fetal Chromosomal Abnormalities
A broader audit of over 140,000 prenatal samples reached a similar conclusion. Replacing full karyotyping with rapid aneuploidy testing alone would have left about one in 100 amniotic fluid samples and one in 40 chorionic villus samples with an undetected abnormality. Roughly 30 percent of the missed amniotic fluid abnormalities and 45 percent of the missed chorionic villus abnormalities carried a substantial risk of an abnormal outcome. The study found that the best protocol for an interpretable result combined a rapid test (FISH or PCR) with a full karyotype.13The Lancet. Prenatal diagnosis of Down’s syndrome, Patau’s syndrome, and Edward’s syndrome by rapid aneuploidy testing (FISH or PCR) – a retrospective cytogenetic audit
In practice, most laboratories now treat FISH as a rapid preliminary result and follow up with a full karyotype or a more comprehensive genomic analysis. FISH tells you quickly whether the most common trisomies are present; karyotyping fills in the rest of the picture.
FISH Compared with QF-PCR and MLPA
FISH is not the only rapid prenatal test available. Quantitative fluorescent PCR (QF-PCR) amplifies short repetitive sequences on the target chromosomes and measures their relative quantities. When applied to prenatal samples, QF-PCR and FISH produce concordant results for trisomies 13, 18, and 21.14Journal of Clinical and Diagnostic Research. Comparison of QF-PCR and FISH for Aneuploidy Detection in Prenatal Diagnosis – Section: Results Both methods are considered reliable, but QF-PCR lends itself more easily to automation and high-throughput processing, while the misdiagnosis risk is slightly higher for FISH.15Reproduction. Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR Many European laboratories have shifted toward QF-PCR as their first-line rapid test for common aneuploidies, partly because it can be run on standard PCR equipment without the fluorescence microscopes and trained technicians that FISH requires.
Another alternative is MLPA (multiplex ligation-dependent probe amplification), which measures copy number at multiple genomic locations simultaneously. MLPA is faster and less expensive than either FISH or karyotyping and has been shown to be comparable to FISH for detecting common aneuploidies.16Journal of Genetic Engineering and Biotechnology. MLPA as a genetic assay for the prenatal diagnosis of common aneuploidy: the first Egyptian experience However, MLPA cannot detect low-grade mosaicism, female triploidies, or copy-number-neutral rearrangements like inversions and balanced translocations.17PubMed. Multiplex Ligation-Dependent Probe Amplification (MLPA) for Prenatal Diagnosis of Common Aneuploidies Each method trades off speed, cost, and comprehensiveness differently, and no single rapid test replaces a full karyotype for structural abnormalities.
The Role of FISH After a Positive NIPT Result
Non-invasive prenatal testing (NIPT) screens for trisomy 21 by analyzing fragments of fetal DNA circulating in the mother’s blood. It has high sensitivity for Down syndrome, but it is still a screening test, not a diagnostic one. False positives occur, sometimes because of confined placental mosaicism, where the placenta carries trisomy 21 but the fetus does not, or because of other biological quirks.
When NIPT comes back positive for trisomy 21, guidelines recommend confirming the result with an invasive procedure before making irreversible decisions. Whether to use chorionic villus sampling (CVS) or amniocentesis for confirmation is debated, but one common approach is to proceed with CVS and examine the sample using FISH on uncultured cells alongside a cultured karyotype. If both show trisomy 21, the result is reported. If there is discordance or mosaicism in the CVS result, amniocentesis is then recommended with both FISH and karyotype analysis.18PubMed. Confined placental mosaicism and its impact on confirmation of NIPT results FISH on the uncultured sample provides the fast answer, while the cultured karyotype provides the definitive one. This two-layer approach helps avoid the scenario where a false-positive NIPT leads to an unnecessary termination.
Automated FISH Interpretation
One of the traditional drawbacks of FISH has been its labor intensity. A trained technician peers through a fluorescence microscope, identifies each nucleus, and manually counts the fluorescent signals. This step is time-consuming and introduces the possibility of human error, especially in high-volume laboratories.
Automated imaging systems have been developed to address this. These platforms capture digital images of stained nuclei and use algorithms to identify and count FISH signals without human intervention. An evaluation of one such system found 100 percent agreement between automated and manual FISH interpretations for amniocentesis specimens.19American Journal of Obstetrics & Gynecology. Automated versus manual FISH interpretations from amniocentesis specimens Automation does not change the underlying biology of the test, but it does reduce the time per sample and the dependence on scarce specialized technicians, which matters in settings where trained cytogeneticists are hard to find.
FISH in Preimplantation Genetic Testing
Outside prenatal diagnosis, FISH has historically been used in preimplantation genetic testing during in vitro fertilization (IVF). In this context, one or two cells are biopsied from an early embryo on day three of development and probed for chromosomal abnormalities before the embryo is transferred to the uterus. The idea is to avoid transferring embryos with trisomy 21 or other aneuploidies.
However, FISH applied to single embryo cells is far less reliable than FISH on prenatal samples containing many nuclei. An analysis of 241 embryos found that the positive predictive value of day-three FISH was about 83 percent and the negative predictive value was about 81 percent. Certain types of abnormalities, including monosomies and trisomies, were confirmed on reanalysis with reasonable reliability, but others were not.17PubMed. Multiplex Ligation-Dependent Probe Amplification (MLPA) for Prenatal Diagnosis of Common Aneuploidies The limited accuracy largely reflects the biological reality that a single cell from a mosaic embryo may not represent the embryo as a whole. For this reason, comprehensive chromosome screening methods that analyze all 23 pairs of chromosomes simultaneously have largely replaced FISH-based preimplantation testing in modern IVF practice.
Cost and Access in Different Healthcare Settings
FISH requires fluorescence microscopes, specific probe kits, and trained technicians, all of which add cost. In high-income healthcare systems, the expense is manageable and offset by the value of a rapid result. In lower-resource settings, the picture is different. Cost-benefit analyses of Down syndrome screening programs in developing countries have found that the most cost-beneficial screening models depend heavily on how expensive each component test is. In one analysis, screening models that incorporated NIPT were most cost-beneficial only when the NIPT cost fell below a certain threshold, with simpler combined-screening approaches proving more economical otherwise.20PubMed Central. Fetal Down syndrome screening models for developing countries; Part II: Cost-benefit analysis
FISH fits into these economics as one layer in a diagnostic cascade. It is less expensive than chromosomal microarray but more expensive and labor-intensive than QF-PCR or MLPA. Laboratories in lower-income countries sometimes skip FISH in favor of QF-PCR for rapid aneuploidy screening because the equipment requirements are simpler. The trade-off is that QF-PCR cannot visualize the physical location of chromosomal material, which means subtle structural rearrangements are harder to detect. In centers where the goal is primarily to rule in or rule out standard trisomy 21 quickly and cheaply, QF-PCR or MLPA may serve just as well. Where the clinical question is more complex, involving possible translocations, partial duplications, or mosaicism, FISH retains a role that is difficult to replicate with purely molecular methods.
When FISH Results Do Not Match the Clinical Picture
Occasionally a prenatal FISH result and the baby’s appearance at birth do not seem to line up. A normal FISH result does not guarantee the absence of all chromosome problems, because the test only examines the chromosomes it is probed for. Conversely, a FISH result showing three signals for chromosome 21 almost always means the fetus has trisomy 21 or at least has extra 21q22 material, but in rare cases of confined placental mosaicism, the abnormality exists in the placenta and not in the fetus itself.
Discordance between interphase and metaphase results, like the case described earlier where interphase showed three signals but metaphase karyotyping looked normal, is another source of confusion. These situations typically prompt additional testing with array-based methods that can detect submicroscopic duplications or deletions invisible to both FISH and standard karyotyping. The clinical lesson is that no single test is infallible. FISH is fast and highly accurate for what it is designed to detect, but it answers a targeted question. When the clinical picture is complicated or the results seem contradictory, layering multiple techniques gives the clearest answer.